Antibody-oligonucleotide conjugates (AOCs) —A new wave of drug conjugates
Di uno scrittore di uomini misteriosi
Descrizione
PDF) On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency
Full article: Enhancement of bioavailability of therapeutics using drug conjugation approach: an in-depth review
rna-10k_20201231.htm
Oligonucleotide conjugates for therapeutic applications
Antibody-oligonucleotide conjugates (AOCs) —A new wave of drug conjugates
JCM, Free Full-Text
Antibody–Oligonucleotide Conjugates as Therapeutic, Imaging, and Detection Agents
WO2020126600A1 - Antibody-drug conjugate with improved therapeutic window - Google Patents
Wells Fargo Adjusts Price Target on Avidity Biosciences to $50 From $55, Maintains Overweight Rating -May 11, 2023 at 11:05 am EDT
Antibody–oligonucleotide (Ab–oligo) conjugation
1188 Antibody substrate oligonucleotide conjugates (ASOCs): a new class of immunotherapeutic agents to inhibit metastasis of tumor cells and block checkpoint inhibition
da
per adulto (il prezzo varia in base alle dimensioni del gruppo)
